Bossard et al., utilizing an ovarian cancer cell line derived from a patient with a stage III poorly differentiated adenocarcinoma, which expressed high endogenous levels of ERα but little ERβ, found that adenovirus reintroduction of ERβ led to an inhibition of both basal and estradiol-induced cell proliferation in vitro. The gene discussed is ESR2; the disease is ovarian cancer.